Celldex Therapeutics (CLDX) Times Interest Earned (2010 - 2026)
Celldex Therapeutics' (CLDX) quarterly Times Interest Earned came in at -$231.96 in Q1 2026, up 38.99% year-on-year from -$166.89 in Q1 2025, and up 98.94% quarter-over-quarter from -$21788.2 in Q4 2025.
Celldex Therapeutics (CLDX) Times Interest Earned (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Times Interest Earned history runs 16 years deep, the most recent figure standing at -$231.96 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 38.99% year-over-year to -$231.96 in Q1 2026; TTM through Mar 2026 was -$849.07, a 35.5% increase from a year earlier, with the FY2025 full-year figure at -$0.77, down 25.77% from the prior year.
- Times Interest Earned grew to -$231.96 in Q1 2026 per CLDX's latest filing, from -$21788.2 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.09 in Q4 2022 and bottomed at -$24539.0 in Q3 2025.
- The 5-year median for Times Interest Earned is -$63.01 (2023), against an average of -$3121.0.
- Across the five-year window, Times Interest Earned jumped 96.91% in 2022 and tumbled 12434839.7% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$0.09 in 2022, then tumbled by 53.78% to -$0.14 in 2023, then slipped by 27.8% to -$0.18 in 2024, then tumbled by 12434839.7% to -$21788.2 in 2025, then soared by 98.94% to -$231.96 in 2026.
- Per Business Quant, the three latest CLDX Times Interest Earned figures stand at -$231.96 (Q1 2026), -$21788.2 (Q4 2025), and -$24539.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | -231.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -231.96 |
| Dec 31, 2025 | -21,788.25 |
| Sep 30, 2025 | -24,539.00 |
| Jun 30, 2025 | -541.16 |
| Mar 31, 2025 | -380.24 |
| Dec 31, 2024 | -0.18 |
| Sep 30, 2024 | -5,212.60 |
| Jun 30, 2024 | -48.60 |
| Mar 31, 2024 | -70.99 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -88.88 |
| Jun 30, 2023 | -63.01 |
| Mar 31, 2023 | -61.04 |
| Dec 31, 2022 | -0.09 |
| Sep 30, 2022 | -10.23 |
| Jun 30, 2022 | -12.08 |
| Mar 31, 2022 | -9.35 |
| Dec 31, 2021 | -0.07 |
| Sep 30, 2021 | -330.54 |
| Dec 31, 2020 | -0.09 |